41326 Federal Register / Vol. 87, No. 132 / Tuesday, July 12, 2022 / Notices 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of May 20, 

2022, FDA published a notice of 

availability with a 60-day comment 

period to provide comments on the draft 

guidance entitled ‘‘Risk Management 

Plans to Mitigate the Potential for Drug 

Shortages.’’ FDA has received requests 

to extend the comment period to allow 

sufficient time to develop and submit 

meaningful comments. FDA has 

considered the requests and is 

extending the comment period until 

August 31, 2022. The Agency believes 

that this extension allows adequate time 

for interested persons to submit 

comments. 

II. Electronic Access 

Persons with access to the internet 

may obtain an electronic version of the 

draft guidance at https://www.fda.gov/ 

drugs/guidance-compliance-regulatoryinformation/guidances-drugs, https://

www.fda.gov/vaccines-blood-biologics/ 

guidance-compliance-regulatoryinformation-biologics, https://

www.fda.gov/regulatory-information/ 

search-fda-guidance-documents, or 

https://www.regulations.gov. 

Dated: July 6, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–14809 Filed 7–11–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID 2022 DMID Omnibus 

BAA (HHS–NIH–NIAID–BAA2022–1) 

Research Area 001: Development of Vaccine 

Candidates for Biodefense, Antimicrobial 

Resistant (AMR) Infections and Emerging 

Infectious Diseases (N01)–1. 

Date: August 3–4, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E72A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Frank S. De Silva, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3E72A, Rockville, MD 

20852, (240) 669–5023, fdesilva@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 6, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–14793 Filed 7–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Opportunities for 

Collaborative Research at the NIH Clinical 

Center. 

Date: July 25, 2022. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2127D, 

Bethesda, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Luis E. Dettin, Ph.D., MS, 

MA, Scientific Review Officer, Scientific 

Review Branch, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, National Institutes of 

Health, 6710B Rockledge Drive, Rm. 2127D, 

Bethesda, MD 20892, (301) 827–8231, luis_

dettin@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.865, Research for 

Mothers and Children, National 

Institutes of Health, HHS) 

Dated: July 6, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–14791 Filed 7–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2022–0206] 

Recertification of Cook Inlet Regional 

Citizens’ Advisory Council 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of recertification. 

SUMMARY: The Coast Guard announces 

the recertification of the Cook Inlet 

Regional Citizens’ Advisory Council 

(CIRCAC) as an alternative voluntary 

advisory group for Cook Inlet, Alaska. 

This certification allows the CIRCAC to 

monitor the activities of terminal 

facilities and crude oil tankers under the 

Cook Inlet Program established by the 

Oil Terminal and Oil Tanker 

Environmental Oversight and 

Monitoring Act of 1990. 

DATES: This recertification is effective 

for the period from September 1, 2022 

through August 31, 2023. 

FOR FURTHER INFORMATION CONTACT: For 

information about this document, call or 

email LT Lauren Bloch, Seventeenth 

Coast Guard District (dpi), by phone at 

(907) 463–2812 or email at 

Lauren.E.Bloch@uscg.mil. 

SUPPLEMENTARY INFORMATION: 


jspears on DSK121TN23PROD with NOTICES1